Imipramine counteracts corticosterone-induced enhancement of glutamatergic transmission and impairment of long-term potentiation in the rat frontal cortex

Pharmacological Reports

Volumn 63, Issue 6, 2011, Pages 1404-1412

  Bobula, Bartosz ^a   Wabno, Joanna ^a   Hess, Grzegorz ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Brain slices; Model of stress; Neocortex; Tricyclic antidepressant

Indexed keywords

CORTICOSTERONE; IMIPRAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ELECTROENCEPHALOGRAM; EX VIVO STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FRONTAL CORTEX; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC TRANSMISSION;

EID: 84856872310     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(11)70704-6     Document Type: Article

References (43)

1. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH: Antidepressant effects of ketamine in depressed patients. Biol Psychiatry, 2000, 47, 351-354. (Pubitemid 30109248)
2. Bijak M, Tokarski K: Prolonged administration of imipramine and (+)-oxaprotiline, but not citalopram, results in sensitization of the rat hippocampal CA1 neurons to serotonin ex vivo. Pol J Pharmacol, 1994, 46, 163-167. (Pubitemid 24250440)
3. Bleakman D, Alt A, Witkin JM: AMPA receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets, 2007, 6, 117-126. (Pubitemid 46681772)
4. Bobula B, Tokarski K, Hess G: Repeated administration of antidepressants decreases field potentials in rat frontal cortex. Neuroscience, 2003, 120, 765-769. (Pubitemid 36928073)
5. Carlson PJ, Singh JB, Zarate Jr CA, Drevets WC, Manji HK: Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx, 2006, 3, 22-41. (Pubitemid 43279517)
6. Checkley S: The neuroendocrinology of depression and chronic stress. Br Med Bull, 1996, 52, 597-617.
7. 1A receptors to 8-OH-DPAT in rat CA1 hippocampal neurons. Naunyn- Schmiedeberg's Arch Pharmacol, 2002, 366, 357-367.
8. Datson NA, van der Perk J, de Kloet ER, Vreugdenhill E: Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neurosci, 2001, 14, 675-689.
9. Feyissa AM, Woolverton WL, Miguel-Hidalgo JJ, Wang Z, Kyle PB, Hasler G, Stockmeier CA et al.: Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry, 2010, 34, 279-283.
10. Fontella FU, Vendite DA, Tabajara AS, Porciúncula LO, da Silva Torres IL, Jardim FM, Martini L et al.: Repeated restraint stress alters hippocampal glutamate uptake and release in the rat. Neurochem Res, 2004, 29, 1703-1709. (Pubitemid 39070060)
11. Gregus A, Wintink AJ, Davis AC, Kalynchuk LE: Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res, 2005, 156, 105-114. (Pubitemid 39330441)
12. Groeneweg FL, Karst H, de Kloet ER, Joëls M: Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol, 2011, 209, 153-167.
13. Hill MN, Brotto LA, Lee TT, Gorzalka BB: Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27, 905-911. (Pubitemid 37141378)
14. Joëls M, Karst H, Alfarez D, Heine VM, Qin Y, van Riel E, Verkuyl M et al.: Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress, 2004, 7, 221-231.
15. Joëls M, Karst H, DeRijk R, de Kloet ER: The coming out of the brain mineralocorticoid receptor. Trends Neurosci, 2008, 31, 1-7.
16. Johnson SA, Fournier NM, Kalynchuk LE: Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav Brain Res, 2006, 168, 280-288. (Pubitemid 43201945)
17. Karten YJ, Slagter E, Joels M: Effect of long-term elevated corticosteroid levels on field responses to synaptic stimulation, in the rat CA1 hippocampal area. Neurosci Lett, 1999, 265, 41-44. (Pubitemid 29210193)
18. Kugaya A, Sanacora G: Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr, 2005, 10, 808-819. (Pubitemid 41531934)
19. Li H, Prince DA: Synaptic activity in chronically injured, epileptogenic sensory-motor neocortex. J Neurophysiol, 2002, 88, 2-12. (Pubitemid 34755326)
20. 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry, 1998, 43, 547-573.
21. Monfils MH, Teskey GC: Skilled-learning-induced potentiation in rat sensorimotor cortex: a transient form of behavioural long-term potentiation. Neuroscience, 2004, 125, 329-336.
22. Morsink MC, Steenbergen PJ, Vos JB, Karst H, Joëls M, De Kloet ER, Datson NA: Acute activation of hippocampal glucocorticoid receptors results in different waves of gene expression throughout time. J Neuroendocrinol, 2006, 18, 239-252. (Pubitemid 43323945)
23. Musazzi L, Racagni G, Popoli M: Stress, glucocorticoids and glutamate release: Effects of antidepressant drugs. Neurochem Int, 2011, 59, 138-149.
24. Palucha A, Pilc A: The involvement of glutamate in the pathophysiology of depression. Drug News Perspect, 2005, 18, 262-268. (Pubitemid 41094930)
25. Parker KJ, Schatzberg AF, Lyons DM: Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav, 2003, 43, 60-66. (Pubitemid 36293275)
26. Paul IA, Skolnick P: Glutamate and depression: clinical and preclinical studies. Ann NY Acad Sci, 2003, 1003, 250-272. (Pubitemid 38083061)
27. Pavlides C, Nivon LG, McEwen BS: Effects of chronic stress on hippocampal long-term potentiation. Hippocampus, 2002, 12, 245-257. (Pubitemid 34436707)
28. Pittenger C, Sanacora G, Krystal JH: The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol Disord Drug Targets, 2007, 6, 101-115. (Pubitemid 46681771)
29. Réus GZ, Stringari RB, Kirsch TR, Fries GR, Kapczinski F, Roesler R, Quevedo J: Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Brain Res Bull, 2010, 81, 585-589.
30. Rioult-Pedotti M-S, Friedman D, Hess G, Donoghue JP: Strengthening of horizontal cortical connections following skill learning. Nat Neurosci, 1998, 1, 230-234.
31. Saez I, Friedlander MJ: Plasticity between neuronal pairs in layer 4 of visual cortex varies with synapse state. J Neurosci, 2009, 29, 15286-15289.
32. Schulz PE: Long-term potentiation involves increases in the probability of neurotransmitter release. Proc Natl Acad Sci USA, 1997, 94, 5888-5893.
33. Simkus CR, Stricker C: Properties of mEPSCs recorded in layer II neurones of rat barrel cortex. J Physiol, 2002, 545, 509-520. (Pubitemid 36004385)
34. Spyrka J, Hess G: Repeated restraint-induced modulation of long-term potentiation in the dentate gyrus of the mouse. Brain Res, 2010, 1320, 28-33.
35. Sterner EY, Kalynchuk LE: Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: Relevance to depression. Prog Neuropsychopharmacol Biol Psychiatry, 2010, 34, 777-790.
36. Szymañska M, Suska A, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Leoekiewicz M, Kubera M et al.: Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex. Pharmacol Rep, 2009, 61, 612-620.
37. Tokarski K, Bobula B, Wabno J, Hess G: Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience, 2008, 153, 789-795.
38. 7 receptors in rat hippocampus. J Physiol Pharmacol, 2009, 60, 83-88.
39. Tokarski K, Urban-Ciecko J, Kossut M, Hess G: Sensory learning-induced enhancement of inhibitory synaptic transmission in the barrel cortex of the mouse. Eur J Neurosci, 2007, 26, 134-141. (Pubitemid 47035434)
40. Yamamoto B, Reagan LP: The glutamatergic system in neuronal plasticity and vulnerability in mood disorders. Neuropsych Dis Treat, 2006, 2, Suppl 2, 7-14.
41. 2 receptors in rat frontal cortex. J Physiol Pharmacol, 2006, 57, 389-399.
42. 4 receptor activation in the CA1 area of rat hippocampus. Eur Neuropsychopharmacol, 2006, 16, 383-390.
43. Zarate C Jr, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G: Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry, 2010, 18, 293-303.